Ophthalmology Highlights 2019
Date: 24/03/2019
Venue: Carousel Albert Park 22 Aughtie Drive Albert Park, VIC, 3205
Provider: Eyes First
Contact: www.trybooking.com/BASAR
Learning Objectives
- Dr Tu Tran “ Critical Diagnosis and Management of Uveitic Glaucoma”
Objectives:
1. How do you diagnose?
2. How do you treat for ocular inflammation and how for glaucoma?
3. When is surgical intervention indicated?
- Dr Wen Lim “ Updates on retinal vein occlusion”
Objectives:
1. Describing ancillary testing in the diagnosis and workup for RVO’s.
2. List key features of relevant clinical trials that guide currect treatment of RVO’s.
3. Understand treatment options for RVO’s.
- Dr Elaine Chong “the transplant-LESS future for Fuch’s endothelial dystrophy”
1. What is it?
2. Who is suitable?
3. When to refer patients?
- Dr Tom Edwards “Latest trends and updates on ERM and retinal holes”
1. How do you grade ERM and retinal holes?
2. Understanding the aetiology and when to refer?
3. Latest treatments and outcomes for both.
- Dr George Kong “MIGS vs other therapies in complicated glaucoma”
1. What are the prerequisites for MIGS surgery?
2. At what stage do you cease drops and refer on for MIGS sx?
3. MIGS vs trabeculectomy outcomes.
- Dr Lana Del Porto “How successful is femtosecond laser and what should patients expect if referred for it”
1. How is modern cataract surgery performed?
2. The uses of femtosecond laser in surgery?
3. To review the latest research findings on LACS.
- Dr Thanh Nguyen “Peripheral retinal findings on widefield imaging”
1. What to look out for on widefield imaging?
2. When to refer based on widefield imaging?
3. Latest trends in widefield imaging.
- Dr Tu Tran
Gonioscopy assessment with LIVE patients
1. To become more familiar with gonioscopy
- Dr Lana Del Porto
Strabismus/Neurological assessment with LIVE patients
1. To become more familiar with examination of strabismus/neurological patients
- Dr Tu Tran, Dr Elaine Chong, Dr Lana Del Porto
Cataract Panel discussion
1. To have answered complex cataract questions
Max points awarded: 18.75
Session Information
| Name |
|---|
| Critical diagnosis and management of uveitic glaucoma |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Updates on retinal vein occlusion |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| LIVE gonioscopy assessment |
| Activity Type |
|---|
| Face to Face without Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Latest trends and updates on ERM and retinal holes |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| The transplant LESS future for Fuch's dystrophy |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| MIGS vs other therapies in complicated glaucoma |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Peripheral retinal findings on widefield imaging |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| How successful is Femtosecond Laser & what should patients expect |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Live Quint/Neuro assessment |
| Activity Type |
|---|
| Face to Face without Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Cataract PANEL Discussion |
| Activity Type |
|---|
| Face to Face without Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/
Supplier? | Points for attending &
Passing Assessment |
|---|
| Critical diagnosis and management of uveitic glaucoma | Face to Face with Assessment | Yes | No | 2.25 |
| Updates on retinal vein occlusion | Face to Face with Assessment | No | No | 2.25 |
| LIVE gonioscopy assessment | Face to Face without Assessment | No | No | 1.00 |
| Latest trends and updates on ERM and retinal holes | Face to Face with Assessment | No | No | 2.25 |
| The transplant LESS future for Fuch's dystrophy | Face to Face with Assessment | No | No | 2.25 |
| MIGS vs other therapies in complicated glaucoma | Face to Face with Assessment | Yes | No | 2.25 |
| Peripheral retinal findings on widefield imaging | Face to Face with Assessment | No | No | 2.25 |
| How successful is Femtosecond Laser & what should patients expect | Face to Face with Assessment | No | No | 2.25 |
| Live Quint/Neuro assessment | Face to Face without Assessment | No | No | 1.00 |
| Cataract PANEL Discussion | Face to Face without Assessment | No | No | 1.00 |